Potentiation of MK-801-induced breathing impairment by 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(F) quinoxaline
- 1 January 1994
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 252 (1), 11-17
- https://doi.org/10.1016/0014-2999(94)90569-x
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Cardiorespiratory effects produced by blockade of excitatory amino acid receptors in catsEuropean Journal of Pharmacology, 1993
- Evidence for an involvement of NMDA and non-NMDA receptors in synaptic excitation of phrenic motoneurons in the rabbitNeuroscience Letters, 1991
- Role of excitatory amino acids in the generation and transmission of respiratory drive in neonatal rat.The Journal of Physiology, 1991
- Endogenous activation of NMDA and non-NMDA glutamate receptors on respiratory neurones in cat medullaNeuropharmacology, 1991
- The Role of Glutamate Neurotoxicity in Hypoxic-Ischemic Neuronal DeathAnnual Review of Neuroscience, 1990
- 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a Neuroprotectant for Cerebral IschemiaScience, 1990
- Involvement of N-methyl-d-aspartate (NMDA) receptors in respiratory rhythmogenesisBrain Research, 1989
- Respiratory effects of the N-methyl-D-aspartate (NMDA) antagonist, MK-801, in intact and vagotomized chronic catsEuropean Journal of Pharmacology, 1988
- (NMDA) receptors control respiratory off-switch in catNeuroscience Letters, 1988
- The novel anticonvulsant MK‐801 binds to the activated state of the N‐methyl‐d‐aspartate receptor in rat brainBritish Journal of Pharmacology, 1987